Naobios
Overview and capabilities of Naobios
Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.
In the news
See all news
Webinar
Are you choosing the right CDMO for your project?
This webinar will explore criteria to consider when selecting a new CDMO to undertake manufacturing of clinical biological substances. Il will take place on 25 November 2021 and will be led by the team at Naobios.
Congress
Meet our teams at CPHI Worldwide
Meet the teams from companies Clean Cells & Naobios next November as they attend CPHI Worldwide.
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.
Over 15 Years
History in GMP and Process Development Activities
A team
of 40 people